Biora Therapeutics Inc (NASDAQ:BIOR) — Market Cap & Net Worth
Market Cap & Net Worth: Biora Therapeutics Inc (BIOR)
Biora Therapeutics Inc (NASDAQ:BIOR) has a market capitalization of $994.99K ($994.99K) as of May 11, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #30205 globally and #5867 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Biora Therapeutics Inc's stock price $0.22 by its total outstanding shares 4522700 (4.52 Million). Analyse how efficiently does Biora Therapeutics Inc generate cash to see how efficiently the company converts income to cash.
Biora Therapeutics Inc Market Cap History: 2020 to 2026
Biora Therapeutics Inc's market capitalization history from 2020 to 2026. Data shows change from $6.00 Billion to $994.99K (-81.08% CAGR).
Biora Therapeutics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Biora Therapeutics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
15264.11x
Biora Therapeutics Inc's market cap is 15264.11 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $6.00 Billion | $74.31 Million | -$192.53 Million | 80.79x | N/A |
| 2021 | $2.36 Billion | $1.25 Million | -$178.52 Million | 1895.04x | N/A |
| 2022 | $149.25 Million | $305.00K | -$38.16 Million | 489.34x | N/A |
| 2023 | $61.06 Million | $4.00K | -$124.11 Million | 15264.11x | N/A |
Competitor Companies of BIOR by Market Capitalization
Companies near Biora Therapeutics Inc in the global market cap rankings as of May 11, 2026.
Key companies related to Biora Therapeutics Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #221 globally with a market cap of $109.05 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #360 globally with a market cap of $74.28 Billion USD.
- UCB SA (BR:UCB): Ranked #510 globally with a market cap of $51.74 Billion USD ( €44.26 Billion EUR).
- argenx NV ADR (NASDAQ:ARGX): Ranked #569 globally with a market cap of $45.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #221 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $109.05 Billion | $429.82 |
| #360 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.28 Billion | $714.89 |
| #510 | UCB SA | BR:UCB | $51.74 Billion | €234.10 |
| #569 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
Biora Therapeutics Inc Historical Marketcap From 2020 to 2026
Between 2020 and today, Biora Therapeutics Inc's market cap moved from $6.00 Billion to $ 994.99K, with a yearly change of -81.08%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $994.99K | 0.00% |
| 2025 | $994.99K | 0.00% |
| 2024 | $994.99K | -98.37% |
| 2023 | $61.06 Million | -59.09% |
| 2022 | $149.25 Million | -93.68% |
| 2021 | $2.36 Billion | -60.64% |
| 2020 | $6.00 Billion | -- |
End of Day Market Cap According to Different Sources
On May 11th, 2026 the market cap of Biora Therapeutics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $994.99K USD |
| MoneyControl | $994.99K USD |
| MarketWatch | $994.99K USD |
| marketcap.company | $994.99K USD |
| Reuters | $994.99K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Biora Therapeutics Inc
Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-fre… Read more